Hyundai Motor America is expanding support for COVID-19 drive-thru testing to 22 hospitals across the US with US$4m in grants through its Hope On Wheels programme. These grants are designed to combat the coronavirus by providing increased access to testing throughout the nation.
The company also announced a donation of 65,000 COVID-19 RT-PCR tests developed by Seegene, a South Korea-based specialist in multiplex molecular diagnostics.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Seegene’s test can simultaneously detect three different genes (N, E and RdRP) of SARS-CoV-2, the virus responsible for COVID-19.
Hyundai claims to be the only automaker providing these testing capabilities to hospitals, especially in hard-hit cities like New Orleans, Chicago and Detroit.
Jose Munoz, president and CEO of Hyundai Motor North America, said: “A best practice that was crucial in South Korea’s handling of the coronavirus was drive-thru testing. This approach protects the healthcare workers and patients from the potential spread of the virus while diagnosing those most in need.”
